Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.
OAKDALE, Minn., June 25, 2025 /PRNewswire/ -- Rove Pest Control, a trusted name in pest management known for its commitment to exceptional service and...
Hedera Foundation Collaborates with The Binary Holdings to Onboard New Users into the Hedera Mobile Gaming Ecosystem.
DUBAI, UAE, June 19, 2025 /PRNewswire/ -- Hedera Foundation...
Health leaders, researchers, and advocates unite to advance efforts against dengue through innovation, prevention, and cross-sector collaboration.
MANILA, Philippines, June 16, 2025 /PRNewswire/ -- As...
Leading Pest Control Company Encourages Action Ahead of National Mosquito Control Awareness Week
VIRGINIA BEACH, Va., June 12, 2025 /PRNewswire/ -- As the nation prepares...